首页 > 最新文献

Advanced research in gastroenterology & hepatology最新文献

英文 中文
Laparoscopic Splenectomy in Non-Cirrhotic Portal Hypertension- A Retrospective Analysis of a Prospectively Performed Series 腹腔镜脾切除术治疗非肝硬化门脉高压症——前瞻性系列手术的回顾性分析
Pub Date : 2021-01-07 DOI: 10.19080/ARGH.2021.16.555937
J. Aluru
In our institute, laparoscopic splenectomy was performed in 27 patients over a period of 7 years for two major indications: hypersplenism and refractory variceal bleeding. 19 patients had Extra Hepatic Portal Venous Obstruction (EHPVO) and 8 patients had Non-Cirrhotic Portal Fibrosis ( NCPF). All the patients had hypersplenism, with thrombocytopenia( < 50,000/cu.mm),leukopenia (< 4000/Cu mm)as well in 9 (33% )of the patients, and anemia ( Hb<10gm) in 8(30%) . Variceal bleeding requiring Endoscopic Variceal Ligation (EVL) were found in 23 patients,17 in the EHPVO group and 6 in the NCPF group . 4 patients were females and 23 were male. The age range was from 12 to 37 years, the mean being 24 years. The laparoscopic procedure was successful in 25, but 2 patients needed conversion to left subcostal laparotomy because of extensive and giant collaterals around the hilum of the spleen; these conversions happened in the first three years of our laparoscopic splenectomy experience, with no conversions in the subsequent 4 years. Even in the presence of a relative contraindication like portal hypertension, laparoscopic splenectomy is still a viable proposition in the vast majority of cases. Technical considerations , like deployment of powerful energy sources, vascular staplers and preliminary splenic artery ligation are discussed in this article.
在我们的研究所,27名患者在7年的时间里进行了腹腔镜脾切除术,主要有两个适应症:脾功能亢进和难治性静脉曲张出血。肝外门静脉阻塞(EHPVO)19例,非肝硬化门脉纤维化(NCPF)8例。所有患者都有脾功能亢进,9例(33%)患者出现血小板减少症(<50000/cu.mm)、白细胞减少症(<4000/cu.mm),8例(30%)患者出现贫血(Hb<10gm)。23例患者出现需要内镜下静脉曲张结扎术(EVL)的静脉曲张出血,EHPVO组17例,NCPF组6例。女性4例,男性23例。年龄范围从12岁到37岁,平均24岁。腹腔镜手术成功25例,但2例患者由于脾门周围有大量巨大的络脉,需要转为左侧肋下剖腹手术;这些转化发生在我们腹腔镜脾切除术经验的前三年,在随后的4年中没有转化。即使存在门静脉高压等相对禁忌症,腹腔镜脾切除术在绝大多数病例中仍然是可行的。本文讨论了技术上的考虑,如部署强大的能源,血管缝合器和初步脾动脉结扎。
{"title":"Laparoscopic Splenectomy in Non-Cirrhotic Portal Hypertension- A Retrospective Analysis of a Prospectively Performed Series","authors":"J. Aluru","doi":"10.19080/ARGH.2021.16.555937","DOIUrl":"https://doi.org/10.19080/ARGH.2021.16.555937","url":null,"abstract":"In our institute, laparoscopic splenectomy was performed in 27 patients over a period of 7 years for two major indications: hypersplenism and refractory variceal bleeding. 19 patients had Extra Hepatic Portal Venous Obstruction (EHPVO) and 8 patients had Non-Cirrhotic Portal Fibrosis ( NCPF). All the patients had hypersplenism, with thrombocytopenia( < 50,000/cu.mm),leukopenia (< 4000/Cu mm)as well in 9 (33% )of the patients, and anemia ( Hb<10gm) in 8(30%) . Variceal bleeding requiring Endoscopic Variceal Ligation (EVL) were found in 23 patients,17 in the EHPVO group and 6 in the NCPF group . 4 patients were females and 23 were male. The age range was from 12 to 37 years, the mean being 24 years. The laparoscopic procedure was successful in 25, but 2 patients needed conversion to left subcostal laparotomy because of extensive and giant collaterals around the hilum of the spleen; these conversions happened in the first three years of our laparoscopic splenectomy experience, with no conversions in the subsequent 4 years. Even in the presence of a relative contraindication like portal hypertension, laparoscopic splenectomy is still a viable proposition in the vast majority of cases. Technical considerations , like deployment of powerful energy sources, vascular staplers and preliminary splenic artery ligation are discussed in this article.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47726823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Acalculous Cholecystitis in a Patient with Covid - 19 Covid - 19患者急性无结石性胆囊炎1例
Pub Date : 2020-12-23 DOI: 10.19080/ARGH.2020.16.555936
A. Palmieri
Acute alithiasic cholecystitis (AAC), also called acalculous, corresponds to the presence of an inflammation of the gallbladder in the absence of stones inside, it is a rare entity (10%), reported in diabetic patients, immunosuppressed, with pathologies infectious (viral, bacterial), major surgery, drugs, multiple trauma, mechanical ventilation, use of vasopressors, opioid analgesics, prolonged fasting, total parenteral nutrition, burns, among others. In this time of the SARS CoV-2 virus / COVID-19 coronavirus disease pandemic, surgeons have found an increase in the request for interconsultations from respiratory hospitalization services, intermediate care and intensive care units, due to ultrasound findings of incidental abdomen of acute alithiasic cholecystitis in those patients without improvement to treatment or worsening of sepsis, or the cytokine cascade, difficult to evaluate abdominal epigastric pain, right upper quadrant, induces us to explore and find little painful palpable gallbladder, reporting edema gallbladder wall greater than 3 mm, gallbladder distention, sometimes ultrasound Murphy’s sign, extending imaging studies according to the patient’s conditions with contrasted computed axial tomography and nuclear magnetic cholangioresonance, and even with reports of micro perforations with peri-vesicular extravasation of contents , free air on its walls, ruling out other causes of acalculous cholecystitis. It is a real diagnostic and therapeutic challenge in these patients with the SARS virus –COV-2 / COVID-19, already afflicted by viremia, or in some cases subjected to cytokine storms, poor general conditions, hermodynamically unstable in Intensive care units, intubated, with vasopressor support, and even some overcoming the emergency, what would be the best time to resolve Acute acalculous cholecystitis medically or surgically? This is the big question.
急性无结石性胆囊炎(AAC),也称为无结石性,对应于胆囊内无结石的情况下存在炎症,是一种罕见的疾病(10%),据报道发生在糖尿病患者、免疫抑制患者、具有传染性(病毒、细菌)、大手术、药物、多发性创伤、机械通气、使用血管升压药、阿片类止痛药、,长期禁食、全胃肠外营养、烧伤等。在SARS CoV-2病毒/新冠肺炎冠状病毒疾病大流行期间,外科医生发现,由于超声发现这些患者的急性急性阿利西亚性胆囊炎腹部意外,治疗没有改善或败血症恶化,因此对呼吸系统住院服务、中间护理和重症监护室的相互咨询请求增加,或难以评估右上腹上腹痛的细胞因子级联反应,诱导我们探索并发现几乎没有疼痛可触及的胆囊,报告胆囊壁水肿大于3毫米,胆囊扩张,有时是超声墨菲征,根据患者的情况,通过对比计算机轴向断层扫描和核磁共振胆管成像,甚至有关于微穿孔和膀胱周围内容物外渗、壁上有自由空气的报道,排除了非结石性胆囊炎的其他原因。对于这些SARS病毒——COV-2/neneneba COVID-19患者来说,这是一个真正的诊断和治疗挑战,他们已经患有病毒血症,或者在某些情况下受到细胞因子风暴、全身状况不佳、在重症监护室中热力学不稳定、插管、使用血管升压药物支持,甚至一些人克服了紧急情况,什么时候是通过医学或手术解决急性无结石性胆囊炎的最佳时机?这是个大问题。
{"title":"Acute Acalculous Cholecystitis in a Patient with Covid - 19","authors":"A. Palmieri","doi":"10.19080/ARGH.2020.16.555936","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555936","url":null,"abstract":"Acute alithiasic cholecystitis (AAC), also called acalculous, corresponds to the presence of an inflammation of the gallbladder in the absence of stones inside, it is a rare entity (10%), reported in diabetic patients, immunosuppressed, with pathologies infectious (viral, bacterial), major surgery, drugs, multiple trauma, mechanical ventilation, use of vasopressors, opioid analgesics, prolonged fasting, total parenteral nutrition, burns, among others. In this time of the SARS CoV-2 virus / COVID-19 coronavirus disease pandemic, surgeons have found an increase in the request for interconsultations from respiratory hospitalization services, intermediate care and intensive care units, due to ultrasound findings of incidental abdomen of acute alithiasic cholecystitis in those patients without improvement to treatment or worsening of sepsis, or the cytokine cascade, difficult to evaluate abdominal epigastric pain, right upper quadrant, induces us to explore and find little painful palpable gallbladder, reporting edema gallbladder wall greater than 3 mm, gallbladder distention, sometimes ultrasound Murphy’s sign, extending imaging studies according to the patient’s conditions with contrasted computed axial tomography and nuclear magnetic cholangioresonance, and even with reports of micro perforations with peri-vesicular extravasation of contents , free air on its walls, ruling out other causes of acalculous cholecystitis. It is a real diagnostic and therapeutic challenge in these patients with the SARS virus –COV-2 / COVID-19, already afflicted by viremia, or in some cases subjected to cytokine storms, poor general conditions, hermodynamically unstable in Intensive care units, intubated, with vasopressor support, and even some overcoming the emergency, what would be the best time to resolve Acute acalculous cholecystitis medically or surgically? This is the big question.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45434849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gastric Plasmablastic Lymphoma, A Very Rare Tumor 胃浆状淋巴瘤,一种非常罕见的肿瘤
Pub Date : 2020-12-10 DOI: 10.19080/ARGH.2020.16.555934
D. A. Ortiz
Plasmablastic lymphoma is a rare variety of diffuse large B-cell lymphoma, regularly aggressive, usually localized in the oral cavity in patients with human immunodeficiency virus infection. Uncommon extraoral locations include the gastrointestinal tract. The endoscopic view of the tumor in the stomach is presented as well as its response to chemotherapy.
浆母细胞淋巴瘤是一种罕见的弥漫性大b细胞淋巴瘤,具有侵袭性,通常局限于人类免疫缺陷病毒感染患者的口腔。不常见的口外部位包括胃肠道。胃内肿瘤的内镜视图,以及它对化疗的反应。
{"title":"Gastric Plasmablastic Lymphoma, A Very Rare Tumor","authors":"D. A. Ortiz","doi":"10.19080/ARGH.2020.16.555934","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555934","url":null,"abstract":"Plasmablastic lymphoma is a rare variety of diffuse large B-cell lymphoma, regularly aggressive, usually localized in the oral cavity in patients with human immunodeficiency virus infection. Uncommon extraoral locations include the gastrointestinal tract. The endoscopic view of the tumor in the stomach is presented as well as its response to chemotherapy.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48841189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut Microbiota and Celiac Disease: Why Eat Gluten-Free if you are not Celiac? 肠道微生物群与腹腔疾病:如果你不是腹腔炎,为什么要吃无麸质?
Pub Date : 2020-12-10 DOI: 10.19080/ARGH.2020.16.555935
A. Sinesi
Celiac disease (CD) is an immune-mediated enteropathy correlated to the gluten ingestion in genetically predisposed subjects. The current and only therapy is a Gluten Free Diet (GFD). In recent years, new therapies and complementary strategies are being studied, including the modulation of the intestinal microbiome. The gut microbiota is involved in the onset and perpetuation of intestinal inflammation of various chronic bowel diseases, including CD. Intestinal dysbiosis has been reported in not treated or treated (with the GFD) celiac individuals, compared to healthy ones. Numerous studies have identified different bacterial clusters associated with CD. However, it’s still unclear whether gut dysbiosis is the cause or effect of CD.
乳糜泻(CD)是一种免疫介导的肠病,与遗传易感性受试者摄入麸质有关。目前也是唯一的治疗方法是无麸质饮食(GFD)。近年来,人们正在研究新的疗法和互补策略,包括调节肠道微生物组。肠道微生物群参与了包括CD在内的各种慢性肠道疾病的肠道炎症的发生和持续。据报道,与健康人相比,未经治疗或治疗(GFD)的腹腔个体存在肠道微生态失调。许多研究已经确定了与CD相关的不同菌群。然而,肠道微生态失调是CD的原因还是影响尚不清楚。
{"title":"Gut Microbiota and Celiac Disease: Why Eat Gluten-Free if you are not Celiac?","authors":"A. Sinesi","doi":"10.19080/ARGH.2020.16.555935","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555935","url":null,"abstract":"Celiac disease (CD) is an immune-mediated enteropathy correlated to the gluten ingestion in genetically predisposed subjects. The current and only therapy is a Gluten Free Diet (GFD). In recent years, new therapies and complementary strategies are being studied, including the modulation of the intestinal microbiome. The gut microbiota is involved in the onset and perpetuation of intestinal inflammation of various chronic bowel diseases, including CD. Intestinal dysbiosis has been reported in not treated or treated (with the GFD) celiac individuals, compared to healthy ones. Numerous studies have identified different bacterial clusters associated with CD. However, it’s still unclear whether gut dysbiosis is the cause or effect of CD.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45601144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Modified BRTO-Assisted Endoscopic Histoacryl Injection for the Treatment of Isolated Gastric Varices with Gastro-Renal Shunt 改良BRTO辅助内镜下注射Histopacryl治疗孤立性胃静脉曲张合并胃-肾分流的安全性和有效性
Pub Date : 2020-11-12 DOI: 10.19080/ARGH.2020.16.555933
wenhui zhang
Background and Aims: Ectopic embolization is the most serious complication of gastric variceal Histoacryl injection for the treatment of Isolated Gastric Varices (IGV) with Gastro-Renal Shunt (GRS). To evaluate the safety and efficacy of modified balloon-occluded retrograde transvenous obliteration-assisted Endoscopic Histoacryl Injection (E-BRTO) for the treatment of IGV with GRS. Methods: Patients that had IGV with significant GRS, treated with E-BRTO, were included in this study. The GRS was temporarily occluded with an occlusion balloon and the IGV was treated by Endoscopic Histoacryl Injection using the “sandwich technique”. Intra- and postoperative complications as well as the IGV eradication, re-bleeding, and recurrence rates were recorded and analyzed. Results: 22 patients were included in this study. The mean volume of Histoacryl used was 16.57±11.76mL. No deaths or serious complications were observed, including ectopic embolism and the worsening of hepatic and renal functions. IGV were eradicated in 22 cases (100%). Abdominal pain and fever was observed in one patient (4.55%), recurrence and re-bleeding of IGV in one patient (4.55%), who was recovery by another Histoacryl injection. Conclusion: E-BRTO is technically feasible, safe, and effective for the treatment of IGV associated with GRS in cirrhotic patients and worthy of clinical application. Keywords:
背景和目的:异位栓塞是胃静脉曲张注射Histoacryl治疗孤立性胃静脉曲张(IGV)合并胃-肾分流(GRS)最严重的并发症。评价改良球囊闭塞逆行经静脉闭塞辅助内镜下Histoacryl注射液(E-BRTO)治疗IGV伴GRS的安全性和有效性。方法:将接受E-BRTO治疗的IGV伴严重GRS的患者纳入本研究。GRS用闭塞球囊暂时闭塞,IGV采用内镜下Histoacryl注射“三明治技术”治疗。记录和分析术中和术后并发症以及IGV根除率、再出血率和复发率。结果:本研究共纳入22例患者。Histoacryl的平均用量为16.57±11.76mL。未观察到死亡或严重并发症,包括异位栓塞和肝肾功能恶化。IGV根除22例(100%)。一名患者(4.55%)出现腹痛和发烧,一名患者出现IGV复发和再次出血(4.55%,该患者通过另一次注射Histoacryl恢复。结论:E-BRTO治疗肝硬化IGV合并GRS在技术上可行、安全、有效,值得临床应用。关键词:
{"title":"Safety and Efficacy of Modified BRTO-Assisted Endoscopic Histoacryl Injection for the Treatment of Isolated Gastric Varices with Gastro-Renal Shunt","authors":"wenhui zhang","doi":"10.19080/ARGH.2020.16.555933","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555933","url":null,"abstract":"Background and Aims: Ectopic embolization is the most serious complication of gastric variceal Histoacryl injection for the treatment of Isolated Gastric Varices (IGV) with Gastro-Renal Shunt (GRS). To evaluate the safety and efficacy of modified balloon-occluded retrograde transvenous obliteration-assisted Endoscopic Histoacryl Injection (E-BRTO) for the treatment of IGV with GRS. Methods: Patients that had IGV with significant GRS, treated with E-BRTO, were included in this study. The GRS was temporarily occluded with an occlusion balloon and the IGV was treated by Endoscopic Histoacryl Injection using the “sandwich technique”. Intra- and postoperative complications as well as the IGV eradication, re-bleeding, and recurrence rates were recorded and analyzed. Results: 22 patients were included in this study. The mean volume of Histoacryl used was 16.57±11.76mL. No deaths or serious complications were observed, including ectopic embolism and the worsening of hepatic and renal functions. IGV were eradicated in 22 cases (100%). Abdominal pain and fever was observed in one patient (4.55%), recurrence and re-bleeding of IGV in one patient (4.55%), who was recovery by another Histoacryl injection. Conclusion: E-BRTO is technically feasible, safe, and effective for the treatment of IGV associated with GRS in cirrhotic patients and worthy of clinical application. Keywords:","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46808952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Indocyanine Green (ICG) in Hepatology 吲哚菁绿在肝病学中的应用
Pub Date : 2020-11-09 DOI: 10.19080/ARGH.2020.16.555932
S. Keiding
The organic anion indocyanine green (ICG) is eliminated solely via hepatobiliary excretion. Consequently, ICG is used to measure the hepatic blood flow by a constant intravenous infusion of ICG, with measurements of ICG blood concentrations in an artery and a hepatic vein, and calculation by Fick’s principle according to simple mass conservation. Secondly, ICG is used to estimate various hepatic clearances, using constant intravenous infusion or bolus injection of ICG and measurements of concentrations of ICG in peripheral blood. These clearance values reflect hepatic blood flow and hepatobiliary excretory function depending on hepatic removal kinetics and systemic blood circulation at the (patho)- physiological condition studied. Third, during recent years, a simple ICG 15-minute retention test (ICG-r15) is developed, using intravenous bolus injection of ICG, measurements of ICG concentration in peripheral blood after 15 minutes, and calculation of percentage ICG of the dose injected which is retained in the body. The ICG-r15 test, which is primarily used to assess the hepatobiliary excretory function but also a wide range of other conditions, is however based on dubious physiological assumptions. In this review, we go through these various applications of ICG measures in hepatology, focusing on physiological background of the tests and their use in studies of liver hemodynamics during normal conditions and liver diseases.
有机阴离子吲哚菁绿(ICG)仅通过肝胆排泄来消除。因此,ICG用于通过持续静脉输注ICG来测量肝血流量,测量动脉和肝静脉中的ICG血浓度,并根据简单质量守恒通过Fick原理进行计算。其次,ICG用于通过持续静脉输注或单次注射ICG和测量外周血中ICG的浓度来估计各种肝脏清除率。这些清除值反映了在所研究的(病理)生理条件下,肝血流量和肝胆排泄功能取决于肝清除动力学和全身血液循环。第三,近年来,开发了一种简单的ICG 15分钟滞留试验(ICG-r15),使用静脉推注ICG,测量15分钟后外周血中的ICG浓度,并计算保留在体内的注射剂量的ICG百分比。ICG-r15测试主要用于评估肝胆排泄功能,也用于评估各种其他情况,但其基于可疑的生理假设。在这篇综述中,我们介绍了ICG测量在肝病学中的各种应用,重点介绍了这些测试的生理背景及其在正常条件下肝脏血流动力学和肝病研究中的应用。
{"title":"Use of Indocyanine Green (ICG) in Hepatology","authors":"S. Keiding","doi":"10.19080/ARGH.2020.16.555932","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555932","url":null,"abstract":"The organic anion indocyanine green (ICG) is eliminated solely via hepatobiliary excretion. Consequently, ICG is used to measure the hepatic blood flow by a constant intravenous infusion of ICG, with measurements of ICG blood concentrations in an artery and a hepatic vein, and calculation by Fick’s principle according to simple mass conservation. Secondly, ICG is used to estimate various hepatic clearances, using constant intravenous infusion or bolus injection of ICG and measurements of concentrations of ICG in peripheral blood. These clearance values reflect hepatic blood flow and hepatobiliary excretory function depending on hepatic removal kinetics and systemic blood circulation at the (patho)- physiological condition studied. Third, during recent years, a simple ICG 15-minute retention test (ICG-r15) is developed, using intravenous bolus injection of ICG, measurements of ICG concentration in peripheral blood after 15 minutes, and calculation of percentage ICG of the dose injected which is retained in the body. The ICG-r15 test, which is primarily used to assess the hepatobiliary excretory function but also a wide range of other conditions, is however based on dubious physiological assumptions. In this review, we go through these various applications of ICG measures in hepatology, focusing on physiological background of the tests and their use in studies of liver hemodynamics during normal conditions and liver diseases.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44879883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late Onset Abdominal Wall Abscess after Laparoscopic Cholecystectomy 腹腔镜胆囊切除术后迟发性腹壁脓肿
Pub Date : 2020-11-05 DOI: 10.19080/ARGH.2020.16.555931
I. KhalidAlhaj
Background: Spillage of gallstones during the extraction of the gallbladder through the abdominal wall incision in laparoscopic cholecystecomy may lead to considerable complications. Methods: We describe an abdominal wall abscess formation in a 50-year-old female that developed 8 months after a laparoscopic cholecystectomy. Results: Undetected spillage of gallstones at the epigastric port site followed by stones migration through subcutaneous plane has lead to abdominal wall abscess formation at hypochondrial area 8 months later. Conclusion: Retained stone should be considered in any patient with foreign body in the subcutaneous tissues after a laparoscopic cholecystectomy. The use of a retrieval device avoids stone spillage. Spilled gallstones always should be removed when possible. In delayed presentations of abdominal wall abscesses due to Spilled gallstones, open drainage of the abscess and open retrieval of the stones followed by antibiotics and daily dressing should achieve adequate results.
背景:腹腔镜胆囊切除术经腹壁切口胆囊取出术中胆结石外溢可能导致相当多的并发症。方法:我们描述了一个50岁的女性腹壁脓肿形成,在腹腔镜胆囊切除术后8个月发展。结果:8个月后,胆囊结石在胃上端未被发现,并经皮下平面迁移,导致疑软骨区腹壁脓肿形成。结论:腹腔镜胆囊切除术后皮下组织异物患者应考虑结石残留。使用回收装置可避免石头外溢。如果可能的话,一定要把溢出的胆结石取出来。由于胆结石外溢而延迟出现腹壁脓肿时,开放引流脓肿和开放取出结石,然后使用抗生素和每日敷料应能达到足够的效果。
{"title":"Late Onset Abdominal Wall Abscess after Laparoscopic Cholecystectomy","authors":"I. KhalidAlhaj","doi":"10.19080/ARGH.2020.16.555931","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555931","url":null,"abstract":"Background: Spillage of gallstones during the extraction of the gallbladder through the abdominal wall incision in laparoscopic cholecystecomy may lead to considerable complications. Methods: We describe an abdominal wall abscess formation in a 50-year-old female that developed 8 months after a laparoscopic cholecystectomy. Results: Undetected spillage of gallstones at the epigastric port site followed by stones migration through subcutaneous plane has lead to abdominal wall abscess formation at hypochondrial area 8 months later. Conclusion: Retained stone should be considered in any patient with foreign body in the subcutaneous tissues after a laparoscopic cholecystectomy. The use of a retrieval device avoids stone spillage. Spilled gallstones always should be removed when possible. In delayed presentations of abdominal wall abscesses due to Spilled gallstones, open drainage of the abscess and open retrieval of the stones followed by antibiotics and daily dressing should achieve adequate results.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46310010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Eosinophilic Enteritis, A Rare Dissease 嗜酸性粒细胞性肠炎,一种罕见的疾病
Pub Date : 2020-10-22 DOI: 10.19080/ARGH.2020.16.555930
A. Rivera
Eosinophilic enteritis is a rare disease characterized by eosinophilic infiltration in the small intestine; In the absence of non-gastrointestinal diseases that cause eosinophilia or causes known as parasites, medications, or malignancies.
嗜酸性粒细胞肠炎是一种罕见的疾病,其特征是小肠嗜酸性粒细胞浸润;在没有引起嗜酸性粒细胞增多症的非胃肠道疾病或寄生虫、药物或恶性肿瘤的情况下。
{"title":"Eosinophilic Enteritis, A Rare Dissease","authors":"A. Rivera","doi":"10.19080/ARGH.2020.16.555930","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555930","url":null,"abstract":"Eosinophilic enteritis is a rare disease characterized by eosinophilic infiltration in the small intestine; In the absence of non-gastrointestinal diseases that cause eosinophilia or causes known as parasites, medications, or malignancies.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45056004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Management of Esophageal Stenosis in Children with Congenital Esophageal Atresia 先天性食管闭锁患儿食管狭窄的内镜治疗
Pub Date : 2020-10-20 DOI: 10.19080/ARGH.2020.16.555929
Deganello Saccomani Marco
Background and Study Aim: Esophageal stenosis (ES) is the most common complication associated with congenital esophageal atresia (EA). There is no consensus regarding the endoscopic management of strictures in terms of timing and techniques of dilation. The aim of this study is to describe the endoscopic approach of esophageal stenosis in children with EA admitted to our tertiary care center. Patients and Methods: A retrospective descriptive single center study was conducted. Data of all patients diagnosed with EA admitted to Woman’s and Child’s University Hospital of Verona, Italy, between 2004 and 2017, were reviewed and collected. For each patient type of EA, associated malformations, age of surgical correction, number and timing of dilations, technique of dilation and side effects of the procedure were registered. Results: Thirty-seven patients with EA were admitted to our center between 2004 and 2017. Twenty of them were excluded from the analysis for insufficient data. Five of the seventeen patients enrolled were affected by VACTERL syndrome and 3 had other congenital malformations. Twelve (70 %) subjects had tracheoesophageal fistula, all of them with type C EA. Three (18%) children presented with long gap EA. All patients underwent surgical correction within 2 months of life and an endoscopic control was performed in all of them. Eleven patients (65%), 8 with Type C EA and 3 with Type A EA, underwent endoscopic dilations because of ES. Eight of them (72%) needed more than one dilation due to anastomotic re- stenosis. Median age of first dilation was 3 months (1-12 months), whereas median age of last dilation was 6 months (1-18 months). Only in one case was used balloon dilator, whereas all other procedures were performed using Savary- Gilliard semi- rigid dilators. One patient (Type C EA with long gap) underwent surgical re-treatment due to an endoscopic complication (fistula recurrence). Six of the seventeen subjects (35%) enrolled developed long-term complications (stridor; severe esophagitis; subglottic stenosis; esophageal diverticulum; dysphagia). Conclusion: Our data confirmed that anastomotic stricture is frequent in patients with EA after surgical correction. Endoscopic management of stenosis is a safe and effective procedure that lead to a limited number of complications. Regular follow-up by a multidisciplinary team is fundamental to prevent and treat short-term and long-term complications.
背景与研究目的:食管狭窄(ES)是先天性食管闭锁(EA)最常见的并发症。在扩张的时机和技术方面,对内镜下狭窄的管理还没有达成共识。本研究的目的是描述我们三级护理中心收治的EA儿童食管狭窄的内镜治疗方法。患者和方法:进行回顾性描述性单中心研究。回顾并收集了2004年至2017年间意大利维罗纳妇女儿童大学医院收治的所有诊断为EA的患者的数据。对于每种类型的EA患者,记录相关畸形、手术矫正年龄、扩张次数和时间、扩张技术和手术副作用。结果:2004年至2017年间,我们中心共收治了37例EA患者。其中20人因数据不足而被排除在分析之外。17名入选患者中有5名患有VACTERL综合征,3名患有其他先天性畸形。12例(70%)受试者有气管食管瘘,均为C型电针。三名(18%)儿童出现长间隙EA。所有患者在出生后2个月内接受了手术矫正,并对所有患者进行了内镜控制。11例(65%),其中8例为C型电针,3例为A型电针,因ES行内镜扩张术。其中8例(72%)因吻合口再狭窄需要多次扩张。第一次扩张的中位年龄为3个月(1-12个月),而最后一次扩张的平均年龄为6个月(8-18个月)。只有一个病例使用球囊扩张器,而所有其他手术都使用Savary-Gilliard半刚性扩张器。一名患者(C型EA,长间隙)因内窥镜并发症(瘘管复发)接受了手术再治疗。入选的17名受试者中有6名(35%)出现长期并发症(喘鸣音;严重食管炎;声门下狭窄;食管憩室;吞咽困难)。结论:我们的数据证实吻合口狭窄在EA患者手术矫正后是常见的。狭窄的内镜治疗是一种安全有效的手术,并发症数量有限。多学科团队的定期随访对于预防和治疗短期和长期并发症至关重要。
{"title":"Endoscopic Management of Esophageal Stenosis in Children with Congenital Esophageal Atresia","authors":"Deganello Saccomani Marco","doi":"10.19080/ARGH.2020.16.555929","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555929","url":null,"abstract":"Background and Study Aim: Esophageal stenosis (ES) is the most common complication associated with congenital esophageal atresia (EA). There is no consensus regarding the endoscopic management of strictures in terms of timing and techniques of dilation. The aim of this study is to describe the endoscopic approach of esophageal stenosis in children with EA admitted to our tertiary care center. Patients and Methods: A retrospective descriptive single center study was conducted. Data of all patients diagnosed with EA admitted to Woman’s and Child’s University Hospital of Verona, Italy, between 2004 and 2017, were reviewed and collected. For each patient type of EA, associated malformations, age of surgical correction, number and timing of dilations, technique of dilation and side effects of the procedure were registered. Results: Thirty-seven patients with EA were admitted to our center between 2004 and 2017. Twenty of them were excluded from the analysis for insufficient data. Five of the seventeen patients enrolled were affected by VACTERL syndrome and 3 had other congenital malformations. Twelve (70 %) subjects had tracheoesophageal fistula, all of them with type C EA. Three (18%) children presented with long gap EA. All patients underwent surgical correction within 2 months of life and an endoscopic control was performed in all of them. Eleven patients (65%), 8 with Type C EA and 3 with Type A EA, underwent endoscopic dilations because of ES. Eight of them (72%) needed more than one dilation due to anastomotic re- stenosis. Median age of first dilation was 3 months (1-12 months), whereas median age of last dilation was 6 months (1-18 months). Only in one case was used balloon dilator, whereas all other procedures were performed using Savary- Gilliard semi- rigid dilators. One patient (Type C EA with long gap) underwent surgical re-treatment due to an endoscopic complication (fistula recurrence). Six of the seventeen subjects (35%) enrolled developed long-term complications (stridor; severe esophagitis; subglottic stenosis; esophageal diverticulum; dysphagia). Conclusion: Our data confirmed that anastomotic stricture is frequent in patients with EA after surgical correction. Endoscopic management of stenosis is a safe and effective procedure that lead to a limited number of complications. Regular follow-up by a multidisciplinary team is fundamental to prevent and treat short-term and long-term complications.","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42860808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Process of Formation the Autoimmune Reaction in the Gastric Mucosa the Damaged Liver 肝损伤后胃黏膜自身免疫反应的形成过程
Pub Date : 2020-10-05 DOI: 10.19080/ARGH.2020.16.555927
I. Trubitsyna
Trubitsyna I*1, Vinokurova L1, Tarasova T2, Lesko K1, Dorofeev A1, Papysheva L1,3, Efremov1, Abdulatipova Z1, Smirnova A1,4 and Varvanina G1 1Moscow clinical research and practice center Of the Moscow Department of health, Russia 2Professor of the Department of psychology of the Historical and sociological Institute of the Federal state budgetary educational institution of higher education, Ogarev Mordovian state University, Russia
Trubitsyna I*1, Vinokurova L1, Tarasova T2, Lesko K1, Dorofeev A1, Papysheva L1,3, Efremov1, Abdulatipova Z1, Smirnova A1,4, Varvanina G1 1俄罗斯莫斯科卫生部莫斯科临床研究与实践中心2俄罗斯Ogarev Mordovian国立大学联邦国家预算高等教育机构历史与社会学研究所心理学系教授
{"title":"The Process of Formation the Autoimmune Reaction in the Gastric Mucosa the Damaged Liver","authors":"I. Trubitsyna","doi":"10.19080/ARGH.2020.16.555927","DOIUrl":"https://doi.org/10.19080/ARGH.2020.16.555927","url":null,"abstract":"Trubitsyna I*1, Vinokurova L1, Tarasova T2, Lesko K1, Dorofeev A1, Papysheva L1,3, Efremov1, Abdulatipova Z1, Smirnova A1,4 and Varvanina G1 1Moscow clinical research and practice center Of the Moscow Department of health, Russia 2Professor of the Department of psychology of the Historical and sociological Institute of the Federal state budgetary educational institution of higher education, Ogarev Mordovian state University, Russia","PeriodicalId":72074,"journal":{"name":"Advanced research in gastroenterology & hepatology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41398047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advanced research in gastroenterology & hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1